Zoetis updates 2026 outlook following third-quarter results
Zoetis reported $2.4 billion in revenue and $591 million in net income for the third quarter of 2026. Following these results, the company narrowed its full-year revenue guidance and raised expectations for adjusted net income.
Key points
- Zoetis revenue for the third quarter of 2026 was $2.4 billion, down 1% from the same period in 2025.
- The company narrowed its full-year revenue guidance to a range of $9.220 billion to $9.320 billion.
Third-quarter financial results.
Zoetis revenue for the third quarter of 2026 was $2.4 billion, down 1% from the same period in 2025. Net income for the period fell 18% to $591 million.
Third-quarter financial figures.
Revenue by quarter, $B
Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.
Updated guidance and operational events.
The company narrowed its full-year revenue guidance to a range of $9.220 billion to $9.320 billion. It also raised adjusted net income expectations to a range of $2.600 billion to $2.640 billion and adjusted diluted earnings per share (EPS) to $6.25 to $6.35. These figures reflect foreign exchange rates as of October 20, 2026.
In October, the company received FDA approval for Convenia RTU for dogs, and Simparica Trio received emergency use authorization. Also, on October 30, 2026, director Mark Stetter received 5.8516 derivative securities as an award valued at $466.49.
Earlier, on October 8, 2026, the company announced a dividend of $0.53 per share for the fourth quarter of 2026, payable on December 1.
What to watch.
Shareholders should monitor future reports to track how actual annual revenue and adjusted net income perform against the updated guidance ranges.
Original sources
- 8-K EX-99.1 filing, November 5, 2026
- 4 filing, November 3, 2026
- 8-K EX-99.1 filing, October 8, 2026
- 8-K filing, October 8, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Zoetis
A notification in your browser or on your phone when we publish about Zoetis. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
